Allogeneic matched-sibling hematopoietic cell transplantation for AML: Comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers

Bone Marrow Transplantation

Volumn 48, Issue 8, 2013, Pages 1065-1069

  Bazarbachi, A ^a   Labopin, M ^b   Ghavamzadeh, A ^c   Giebel, S ^d   Al Zahrani, H ^e   Ladeb, S ^f   Leone, G ^g   Abdel Rahman, F ^h   Liso, V ⁱ   Hamidieh, A A ^c   Rasheed, W ^e   Ibrahim, A ^j   Alabdulaaly, A ^k   Kyrcz Krzemien, S ^l   Arnold, R ^m   Kharfan Dabaja, M A ^a   Alimoghaddam, K ^c   Aljurf, M ^e   Mohty, M ⁿ  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b HÔPITAL SAINT ANTOINE   (France)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^f CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^g CATHOLIC UNIVERSITY   (Italy)

^h KING HUSSEIN CANCER CENTER   (Jordan)

ⁱ UNIVERSITY OF BARI   (Italy)

^j MAKASSED GENERAL HOSPITAL   (Lebanon)

^k The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^l MEDICAL UNIVERSITY OF SILESIA   (Poland)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ UNIVERSITÉ DE NANTES   (France)

more..

Author keywords

Allogeneic BMT; AML; EBMT; EMBMT; Emerging centers

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EUROPE; FEMALE; GRAFT RECIPIENT; HEALTH CARE PLANNING; HLA MATCHING; HUMAN; LEUKEMIA FREE SURVIVAL; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; NON RELAPSE MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RECURRENCE RISK; RETROSPECTIVE STUDY; SIBLING; SOCIAL STATUS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LIVING DONORS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; RETROSPECTIVE STUDIES; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881374548     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.1     Document Type: Article

References (17)

1. Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D et al. Age and acute myeloid leukemia: Real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 2009; 113: 4179-4187
2. Buchner T, Berdel WE, Haferlach C, Haferlach T, Schnittger S, Muller-Tidow C et al. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: A study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol 2009; 27: 61-69
3. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333
4. Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLAidentical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-Aged adults: Benefits for whom? Blood 2007; 109: 3658-3666
5. Suciu S, Mandelli F, de Witte T, Zittoun R, Gallo E, Labar B et al. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): An intention-To-Treat analysis of the EORTC/GIMEMAAML-10 trial. Blood 2003; 102: 1232-1240
6. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-Analysis of prospective clinical trials. JAMA 2009; 301: 2349-2361
7. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: A global perspective. JAMA 2010; 303: 1617-1624
8. Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393-1398
9. Aljurf M, Zaidi SZ, Hussain F, Ghavamzadeh A, Alimoghaddam K, Jahani M et al. Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO). Transfus Apher Sci 2010; 42: 169-175
10. Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK et al. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. Bone Marrow Transplant 2009; 43: 1-12
11. Anasetti C. What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation? Best Pract Res Clin Haematol 2008; 21: 691-697
12. Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214-3219
13. Al Husain M, Al Bunyan M. Consanguineous marriages in a Saudi population and the effect of inbreeding on prenatal and postnatal mortality. Ann Trop Paediatr 1997; 17: 155-160
14. Khoury SA, Massad D. Consanguineous marriage in Jordan. Am J Med Genet 1992; 43: 769-775
15. Al-Gazali LI, Bener A, Abdulrazzaq YM, Micallef R, al-Khayat AI, Gaber T. Consanguineous marriages in the United Arab Emirates. J Biosoc Sci 1997; 29: 491-497
16. Giebel S, Labopin M, Ehninger G, Beelen D, Blaise D, Ganser A et al. Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. Blood 2010; 116: 122-128
17. Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J et al. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol 2011; 29: 1980-1986